Clinical Evaluation of Ksharagad for the Management of Swelling Disorders

A clinical study on Ksharagad in management of Shotha

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102349

Enrollment

Registered

2026-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a. Patient willing for the research trial. b. Patients between age group of 15 to 65 years. d. In patient, all type of Shotha (Vishjanya).

Exclusion criteria

Exclusion criteria: a. Pregnant women, lactating women. b. Patients are not willing for trial and support. c. Patients having severe disease like AIDS, Cancer, Diabetes, T.B, Severe Heart disease, Jaundice, Renal failure, Anxiety, disorder etc. d. Diabetic patient e. Chronicity more than 5year f. Falariasis

Design outcomes

Primary

Measure	Time frame
Measurement of size / circumference of swelling (cm) Clinical grading of swelling (0 3 scale: none, mild, moderate, severe) Pain associated with swelling (VAS / grading scale) Local tenderness and temperatureTimepoint: 8 weeks	—

Secondary

Measure	Time frame
Reduction in pain associated with swelling assessed using Visual Analog Scale (VAS) or grading scale. Reduction in local tenderness assessed clinically. Reduction in local warmth / inflammation on palpation. Improvement in functional ability of affected part (movement, daily activity limitation). Overall clinical improvement assessed by physician global assessment. Safety assessment based on occurrence of any adverse events during treatment.Timepoint: Baseline (Day 0) Day 7 Day 14 End of Treatment (Day 28)	—

Measure

Time frame

Reduction in pain associated with swelling assessed using Visual Analog Scale (VAS) or grading scale. Reduction in local tenderness assessed clinically. Reduction in local warmth / inflammation on palpation. Improvement in functional ability of affected part (movement, daily activity limitation). Overall clinical improvement assessed by physician global assessment. Safety assessment based on occurrence of any adverse events during treatment.Timepoint: Baseline (Day 0) Day 7 Day 14 End of Treatment (Day 28)

—

Countries

India

Contacts

Public ContactDr (prof) Jai Kumar Singh

Government ayurvedic college and hospital, Patna

jai.kumar1966@rediffmail.com9199373517

Outcome results